Hydroaktives Polyurethanpflaster zur Behandlung hypertropher Narben und Keloide

Zusammenfassung

Zur Beurteilung der Wirksamkeit eines hydroactiven Polyurethanpflasters bei hypertrophen Narben und Keloiden wurde eine offene Studie an 46 Patienten durchgeführt. Eine Verbesserung der klinischen Zielparameter ließ sich bei einer Behandlungszeit von 8 - 12 Wochen bei nahezu allen Patienten feststellen, wobei die Handhabung problemlos und einfach, die Verträglichkeit überwiegend sehr gut war. Das hier geprüfte Polyurethanpflaster stellt somit eine zusätzliche Alternative in der immer noch schwierigen Behandlung keloidaler Narben dar.

Abstract

For evaluation of the effectivness of a hydroactive polyurethan plaster in the treatment of keloid scars an open study was conducted. 46 patients were included. An improvement of the clinical parameters could be detected in nearly all participants during the study time of 8 - 12 weeks. The handling of the plaster was easy, the tolerability mostly good. Therefore this polyurethan dressing seems to be a further alternative in the still difficult therapy of keloid scars.

Literatur

• 1 Baum T M, Busuito M J. Use of a glycerin-based gel sheeting in Scar Management.  Adv in wound care. 1998;  11 40-43
• 2 Bieley H C, Berman B. Effects of waterimpermeable, non-silicone-based occlusive dressing on keloids.  J Am Acad Dermatol. 1996;  35 113-114
• 3 Bock 0, Mrowietz U. Keloide - eine dermale fibroproliferative Erkrankung unbekannter Ursache.  Hautarzt. 2002;  53 515-523
• 4 Eckes B, Zigrino P, Kessler D, Holtkötter O, Shephard P, Mauch C, Krieg T. Fibroblasmatrix interactions in wound healing and fibrosis.  Matrix Biol. 2000;  19 325-332
• 5 Ehrlich H P, Desmouliere A, Diegelmann R F, Cohen I K, Compton C C, Garber W L. Morphological and immunochemical differences between keloid and hypertrophic scars.  Am J Pathol. 1994;  145 105-113
• 6 Espana A, Solano T, Quintanilla E. Bleomycin in the treatment of keloids and hypertrophic scars by multiple needle punctures.  Dermatol Surg. 2001;  27 23-27
• 7 Farrior R T, Stambaugh K I. Keloids and hyperplastic scars. In: Thomas JR., Holt GR. (Hrsg) Facial scars, revisions, and camouflage. St Louis; CV Mosby 1989: 211-228
• 8 Fitzpatrick R E. Treatment of inflamed hypertrophic scars using intralesional 5-FU.  Dermatol Surg. 1999;  25 224-232
• 9 Friedmann D W, Boyd C D, Mackenzie J W, Norton P, Olson R M, Deak S B. Regulation of collagen gene expression in keloids and hypertrophic scars.  J Surg Res. 1993;  55 214-222
• 10 Gold M H. A controlled clinical trial of topical silicone gel sheeting in the treatment of hypertrophic scars and keloids.  J Am Acad Dermatol. 1994;  30 506-507
• 11 Goslen J B. The role of steroids in preventing scar formation. In: Thomas JR., Holt GR (Hrsg) Facial scars, revisions, and camouflage. St. Louis; CV Mosby 1989: 83-97
• 12 Hellwig S. , Raulin C. Gepulste Laser in der Narbenbehandlung.  Hautarzt. 1999;  50 465-469
• 13 Klopp R, Niemer W, von der Werth A. Randomized comparative study of the effects of different dressing administrations on the formation of scars after surgical incisions.  Wound Repair and Regeneration. 1998;  6/5 A 473
• 14 Philipps T J, Gerstein A D, Lordan V. A randomized controlled trial of hydrocolloid dressing in the treatment of hypertrophic scars and keloids.  Dermatol Surg. 1996;  22 775-778
• 15 Ricketts C H, Martin L, Faria D T, Saed G M, Fivenson D P. Cytokine mRNA chages during the treatment of hypertrophic scars with silicone and nonsilicone gel dressings.  Dermatol Surg. 1996;  22 955-959
• 16 Roberts A B. Molecular and cell biology of TGF-beta.  Miner Electrolyte Metab. 1998;  24 111-119
• 17 Rusciani L, Rossi G, Bono R. Use of cryotherapy in the treatment of keloids.  J Dermatol Surg Oncol. 1993;  19 529-534
• 18 Sherris D A, Larrabee W F, Murakami C S. Management of scar contractures, hypertrophic scars, and keloids.  Otolaryngol Clin North Am. 1995;  28 1957-1968
• 19 Singer A J, Clark R AF. Cutaneous wound healing.  NEJM. 1999;  341 738-746
• 20 Tredget E E, Nedelec B, Scott P G, Ghahary A. Hypertrophic scars, keloids, and contractures. The cellular and molecular basis for therapy.  Surg Clin North Am. 1997;  77 701-730